FRONTEO, Inc. American Depositary Shares
FTEO
FTEO was delisted on the 12th of February, 2020.
5 hedge funds and large institutions have $217K invested in FRONTEO, Inc. American Depositary Shares in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
10% more capital invested
Capital invested by funds: $198K → $217K (+$19K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$39.1K |
| 2 |
Citigroup
New York
|
+$1.23K |
| 3 |
Morgan Stanley
New York
|
+$32 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.26K |
FTEO Hedge Fund Activity: Q2 2015 in Review
5 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in FRONTEO, Inc. American Depositary Shares (FTEO) for Q2 2015, worth a combined $217K — up 9.6% from $198K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new FTEO positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, adding an estimated $39.1K. The largest seller was Tower Research Capital (TRC), cutting an estimated $13.8K.
- 5 institutional investors held FRONTEO, Inc. American Depositary Shares (FTEO) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $217K of FRONTEO, Inc. American Depositary Shares stock for Q2 2015, up 9.6% quarter-over-quarter.
- 1 fund opened new FRONTEO, Inc. American Depositary Shares positions in Q2 2015 and 0 closed out, a net change of +1 holder.
- The largest FRONTEO, Inc. American Depositary Shares buyer in Q2 2015 was Jane Street, an estimated $39.1K added.
- The largest FRONTEO, Inc. American Depositary Shares seller in Q2 2015 was Tower Research Capital (TRC), an estimated $13.8K sold.
Based on aggregated 13F filings for Q2 2015.